199 related articles for article (PubMed ID: 33262462)
1. STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.
Lin WH; Chang YW; Hong MX; Hsu TC; Lee KC; Lin C; Lee JL
Oncogene; 2021 Jan; 40(4):791-805. PubMed ID: 33262462
[TBL] [Abstract][Full Text] [Related]
2. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
Jin W
Cells; 2020 Jan; 9(1):. PubMed ID: 31952344
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Lazor JW; Sperry J; Jin C; Cao L; Freeman JW
Cancer Res; 2008 Jun; 68(11):4221-8. PubMed ID: 18519681
[TBL] [Abstract][Full Text] [Related]
4. STAT3 phosphorylation at tyrosine 705 and serine 727 differentially regulates mouse ESC fates.
Huang G; Yan H; Ye S; Tong C; Ying QL
Stem Cells; 2014 May; 32(5):1149-60. PubMed ID: 24302476
[TBL] [Abstract][Full Text] [Related]
5. SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan LC; Shiau CW; Tai WT; Hung MH; Chu PY; Hsieh FS; Lin H; Yu HC; Chen KF
Oncogene; 2015 Oct; 34(41):5252-63. PubMed ID: 25619838
[TBL] [Abstract][Full Text] [Related]
6. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
7. ZnAs@SiO
Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
[No Abstract] [Full Text] [Related]
8. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
10. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Gao S; Hu J; Wu X; Liang Z
Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
[TBL] [Abstract][Full Text] [Related]
11. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis.
Zhao Z; Cheng X; Wang Y; Han R; Li L; Xiang T; He L; Long H; Zhu B; He Y
PLoS One; 2014; 9(4):e95884. PubMed ID: 24789104
[TBL] [Abstract][Full Text] [Related]
13. The effect of mesenchymal stem cells' secretome on lung cancer progression is contingent on their origin: primary or metastatic niche.
Attar-Schneider O; Drucker L; Gottfried M
Lab Invest; 2018 Dec; 98(12):1549-1561. PubMed ID: 30089856
[TBL] [Abstract][Full Text] [Related]
14. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
15. PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness.
Streitfeld WS; Dalton AC; Howley BV; Howe PH
Cancer Biol Ther; 2023 Dec; 24(1):2271638. PubMed ID: 37927213
[TBL] [Abstract][Full Text] [Related]
16. Phospho-Ser727 triggers a multistep inactivation of STAT3 by rapid dissociation of pY705-SH2 through C-terminal tail modulation.
Yang J; Kunimoto H; Katayama B; Zhao H; Shiromizu T; Wang L; Ozawa T; Tomonaga T; Tsuruta D; Nakajima K
Int Immunol; 2020 Feb; 32(2):73-88. PubMed ID: 31555812
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway.
Shen M; Xu Z; Xu W; Jiang K; Zhang F; Ding Q; Xu Z; Chen Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):149. PubMed ID: 30961670
[TBL] [Abstract][Full Text] [Related]
18. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.
Balanis N; Wendt MK; Schiemann BJ; Wang Z; Schiemann WP; Carlin CR
J Biol Chem; 2013 Jun; 288(25):17954-67. PubMed ID: 23653350
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
20. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.
Rokavec M; Öner MG; Li H; Jackstadt R; Jiang L; Lodygin D; Kaller M; Horst D; Ziegler PK; Schwitalla S; Slotta-Huspenina J; Bader FG; Greten FR; Hermeking H
J Clin Invest; 2014 Apr; 124(4):1853-67. PubMed ID: 24642471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
